Status:
COMPLETED
A Singapore Pilot Study to Assess Neurovision in Treatment of Low Myopia
Lead Sponsor:
Singapore National Eye Centre
Collaborating Sponsors:
Singapore Eye Research Institute
NeuroVision
Conditions:
Myopia
Eligibility:
All Genders
15-55 years
Phase:
PHASE1
Brief Summary
To assess how well and safe is Neurovision technology in improving the vision of people with low myopia in Singapore
Detailed Description
The eye care industry has focused a majority of its resources on solving problems associated with the ocular or "front end" of the visual system. These investments have led to exciting technology adva...
Eligibility Criteria
Inclusion
- The subject's cycloplegic spherical equivalence in the worst eye does not exceed -1.5 DS and the astigmatism does not exceed 0.50 DC.
- The subject's refractive status is stable, with no increase beyond 0.5D in sphere or cylinder over the last six months.
- The subject's age is between 17-55 years.
- The subject's uncorrected visual acuity 0.7 LogMar
- The subject's best corrected visual acuity 0.05 LogMar
- The subject is cognitively intact and is able to follow multiple step instructions.
- The subject is able and willing to attend all study sessions and visits at the required frequency:
- The total number of treatments is individual, approximately 30.
- The required pace for the treatment sessions is at least 3 sessions per week.
- No foreseen interruptions longer than 2 weeks during the treatment course.
- Subject (or subject's parent/legal guardian if subject is less than 21 years of age at study entry) agrees to sign the Informed Consent Form (See Appendix D)
Exclusion
- The subject suffers from any other eye disease(s) or other causes for the reduced visual acuity, aside from myopia and/or astigmatism.
- The subject suffers from myopia-related visual complications resulting in visual loss, including myopic macular degeneration, myopic cataract and previous or pre-existing myopic retinal detachment.
- The subject is suffering from Diabetes Mellitus.
- The subject has previously undergone a refractive surgery procedure in either eye.
- The subject is or may be pregnant.
- The subject has an activity limitation due to medical disorders (including migraines, seizure disorders, etc.), medications, or emotional status that might potentially impair the subject's ability to perform the treatment.
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00348127
Start Date
March 1 2003
End Date
October 1 2004
Last Update
June 24 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore Eye Research Institute
Singapore, Singapore, 168751